These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9846419)

  • 21. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment with cytostatic agents should be considered in colorectal cancer. It improves prognosis and quality of life].
    Larsson PA
    Lakartidningen; 1999 May; 96(19):2314-6. PubMed ID: 10377671
    [No Abstract]   [Full Text] [Related]  

  • 23. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
    Allal AS; Nicoucar K; Mach N; Dulguerov P
    Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06.
    Kopec JA; Yothers G; Ganz PA; Land SR; Cecchini RS; Wieand HS; Lembersky BC; Wolmark N
    J Clin Oncol; 2007 Feb; 25(4):424-30. PubMed ID: 17264338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten-year historic cohort of quality of life and sexuality in patients with rectal cancer.
    Schmidt CE; Bestmann B; Küchler T; Longo WE; Kremer B
    Dis Colon Rectum; 2005 Mar; 48(3):483-92. PubMed ID: 15747079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
    Law WL; Ho JW; Chan R; Au G; Chu KW
    Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy for colorectal carcinoma.
    Kim R; Yamaguchi Y; Toge T
    Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of postoperative adjuvant chemotherapy for colorectal cancer].
    Nozoe Y; Ogata Y; Miyagi Y; Nakagawa M; Matono K; Sasatomi T; Araki Y; Shirouzu K
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):67-72. PubMed ID: 11816480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy of colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević Z
    Srp Arh Celok Lek; 1998; 126(11-12):506-11. PubMed ID: 9921027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptom experiences during chemotherapy treatment--with focus on nausea and vomiting.
    Bergkvist K; Wengström Y
    Eur J Oncol Nurs; 2006 Feb; 10(1):21-9. PubMed ID: 15908274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
    Wiboltt K; Raskov HH
    Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
    J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant treatment in colorectal cancer. Experience from a referral center in eastern peninsular Malaysia.
    Biswal BM; Sain AH; Othman NH; Baba A
    Trop Gastroenterol; 2002; 23(3):134-7. PubMed ID: 12693156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer.
    Camilleri-Brennan J; Steele RJ
    Br J Surg; 2001 Dec; 88(12):1617-22. PubMed ID: 11736975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.